Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive...

Area of Science:

• Gerontology
• Neuropsychology
• Cognitive Assessment

Background:

• The Revised Cambridge Cognitive Examination (CAMCOG-R) is a widely used cognitive screening tool for differentiating dementia from normal cognition in older adults.
• While the CAMCOG-R assesses multiple cognitive domains, the construct validity of its subscores, particularly Memory and Executive Function, remains underexplored.
• Establishing the validity of these subscores is crucial for accurate clinical interpretation and diagnosis.

Purpose of the Study:

• To evaluate the construct validity of the CAMCOG-R Memory and Executive Function subscores.
• To compare the performance of these subscores against extensive neuropsychological assessments in older adults with and without cognitive decline.
• To determine the diagnostic accuracy (sensitivity and specificity) of the CAMCOG-R subscores for memory and executive dysfunction.

Main Methods:

• An observational study was conducted in a memory clinic setting.
• Participants included 36 outpatients with diagnosed cognitive decline and 24 cognitively healthy older adults.
• The CAMCOG-R Memory and Executive Function subscores were validated against comprehensive neuropsychological tests serving as the gold standard.

Main Results:

• The CAMCOG-R Executive Function subscore demonstrated good sensitivity (0.82) and adequate specificity (0.73) for identifying executive dysfunction at a cutoff of 16.5.
• The CAMCOG-R Total Score and Language subscore also showed ability to differentiate individuals with and without executive dysfunction.
• Critically, the CAMCOG-R Memory subscore failed to demonstrate valid discrimination between individuals with and without memory impairment.

Conclusions:

• The construct validity of the CAMCOG-R Memory and Executive Function subscores is limited.
• Clinicians should exercise caution when interpreting these specific CAMCOG-R subscores, especially in the absence of supplementary neuropsychological data or detailed clinical information.
• Further research may be needed to refine or validate these subscores for clinical use.